Fund
Teikoku Ventures
Teikoku Ventures took part in the round of Celaid Therapeutics (400 M JPY, Series B) on 5 October 2026. It is the only health round Bolus has logged for it so far.
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 1
- Lead
- 0
- New entries
- 1
- Follow ons
- 0
- Latest operation
- 5 October 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 05 Oct | Japan, Biotech | Series B | 400 M JPY | Participant |
Co investors 1 funds crossed
Funds that appeared in the same rounds, in any capacity. Geographies logged: Japan.